Zivo Bioscience, Inc.·4

Apr 5, 5:10 PM ET

PAYNE JOHN BERNARD 4

4 · Zivo Bioscience, Inc. · Filed Apr 5, 2023

Insider Transaction Report

Form 4
Period: 2023-04-03
PAYNE JOHN BERNARD
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock Purchase Warrant

    2023-04-03+390,000390,000 total
    Exercise: $2.91From: 2023-04-03Exp: 2026-04-02Common Stock (390,000 underlying)
Footnotes (1)
  • [F1]The warrant was issued in connection with a private placement and purchase of a promissory note by Mr. Payne in the principal amount of $1,000,000.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT